FDA Approved- JUVEDERM XC formulated with lidocaine

April 6, 2010 - PRLog -- Allergan, Inc. announced on Feb. 2, 2010 the FDA approval for JUVÉDERM® XC. JUVÉDERM® is a smooth consistency gel made of hyaluronic acid – a naturally occurring substance in your skin that helps to add volume and hydration. JUVÉDERM® is injected under the skin to instantly restore your skin's volume and smooth away facial wrinkles and folds, like your “smile lines” or “parentheses”. With JUVÉDERM® the injection process takes only about 15 minutes and results are immediate. Plus, there’s minimal recovery or downtime. Now with JUVÉDERM® XC, the treatment area becomes numb in seconds. Patients will receive the same great results while spending less time in the doctor’s office and enjoying a more comfortable experience.

Juvederm XC’s approval was based on data from a multi-center, double-blind, randomized clinical trial which was conducted with 72 patients. Results showed that 93% of the patients experienced less pain when treated with Juvederm XC compared to patients receiving the non-lidocaine formulation of Juvederm. Moreover, the product was found to be more effective in reducing procedural pain while maintaining a similar safety and effectiveness profile as the non-lidocaine formulation.

Dr. Amy Forman Taub, Owner and Medical Director of Advanced Dermatology in Lincolnshire, IL feels, “for people who have stayed away from renewing their fillers or starting fillers due to fear of pain, this is their chance to have a much more comfortable experience with injectables.”

Dr. Amy Forman Taub founded Advanced Dermatology, Skinfo® Specialty Skincare Boutique and SKINQRI in Lincolnshire, Illinois.  Advanced Dermatology is a state-of-the-art medical and cosmetic dermatology practice nationally recognized for excellence in dermatologic care. Skinfo and skinfo.com, a professional skincare website, offer physician-dispensed and cosmeceutical-grade skincare products and product information to the public. In 2006, Dr. Taub founded SKINQRI, Advanced Research in Dermatology.  SKINQRI collaborates with pharmaceutical skincare and laser and other medical device companies to test the safety and efficacy of new treatments and evaluate new protocols for current treatments.  Dr. Taub's practice philosophy is one of active collaboration with her patients.  While she likes being on the cutting edge of technological and medical innovations, Dr. Taub carefully evaluates the scientific principles and safety of new treatments and procedures she makes available to her patients.

Born and raised in the Chicago area, Dr. Taub graduated from Northwestern University Medical School in 1985 and completed her internal medicine internship and dermatology residency at its affiliated hospital, Northwestern Memorial, in 1989. Dr. Taub is currently an Assistant Clinical Professor at Northwestern University Medical School. Prior to opening Advanced Dermatology, Dr. Taub was the Medical Director for the Division of Dermatology of Northwestern Memorial Physicians Group.

As a consultant to leading laser and drug companies, Dr. Taub also educates and trains physicians from all over the country to provide cosmetic and laser procedures.  Dr. Taub is a member (Fellow) of the American Academy of Dermatology (AAD), the American Society for Dermatologic Surgery (ASDS), the American Society for Laser Surgery and Medicine (ASLMS), the Chicago Dermatologic Society, and the Illinois State Dermatologic Society.  Dr. Taub is also a Charter Board of Director for the American Society of Photodynamic Therapy (ASPDT), a member of the Leaders Society to the Dermatology Foundation, on the Advisory Council of the Skin Cancer Foundation, and on the Research Committee for the ASDS.

# # #

Located in Lincolnshire, a suburb of Chicago, Illinois, Advanced Dermatology offers the latest innovations in cosmetic and dermatological skin care treatments and procedures in a beautiful, state-of-the-art professional office.